Lipid metabolism for predicting the recurrence of hypertriglyceridemic acute pancreatitis. 2023

Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
Department of Radiology, Affiliated Hospital of North Sichuan Medical College, No.1 Maoyuan South Road, Shunqing District, Nanchong, 637000, China.

To investigate the predictive value of lipid metabolism in predicting the recurrence of hypertriglyceridemic acute pancreatitis (HTG-AP). A total of 892 patients were admitted to our hospital for acute pancreatitis (AP) from January 2017 to December 2020, of whom 198 diagnosed with HTG-AP were enrolled in this retrospective study. Demographic information, length of stay, smoking index, alcohol abuse, necrosis, severity, baseline lipid metabolism and other blood biochemical indicators were recorded. The risk factors of recurrence were evaluated using univariate and multivariate Cox proportional risk analyses, and the cumulative recurrence-free survival rate of patients were calculated using Kaplan Meier method and the differences between groups were compared using the log-rank test. Univariate and multivariate analysis showed that triglyceride (hazard ratio, 2.421; 95% CI, 1.152-5.076; P = 0.020), non high-density lipoprotein (hazard ratio, 4.630; 95% CI, 1.692-12.658; P = 0.003) and apolipoprotein A1 (hazard ratio, 1.735; 95% CI, 1.093-2.754; P = 0.019) were important predictors for recurrence of HTG-AP. Subsequently, patients were divided into four groups according to the cut off values of triglyceride, non high-density lipoprotein and apolipoprotein A1. It was found that the cumulative recurrence-free survival rate of patients in highest-risk group or high-risk group was significantly lower than that of medium-risk group (P < 0.001, P = 0.003) or low risk group (P < 0.001). Serum triglycerides, non high-density lipoprotein and apolipoprotein A1 are independent predictors of recurrence in HTG-AP patients, which can provide reference for individualized treatment and prevention of recurrence in HTG-AP patients.

UI MeSH Term Description Entries

Related Publications

Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
October 2023, Journal of digestive diseases,
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
May 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
January 2015, Medicina intensiva,
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
November 1973, Polskie Archiwum Medycyny Wewnetrznej,
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
April 1978, Polskie Archiwum Medycyny Wewnetrznej,
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
January 1970, Klinicheskaia khirurgiia,
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
May 2024, Pancreas,
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
January 2023, Frontiers in medicine,
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
November 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Lingling Tang, and Qing Jia, and Nian Liu, and Qianqian Liu, and Ke Pan, and Lixing Lei, and Xiaohua Huang
April 1987, Nihon Geka Gakkai zasshi,
Copied contents to your clipboard!